Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling

Han, Baoai; Zhang, He; Tian, Ruinan; Liu, Hui; Wang, Zhaosong; Wang, Zhiyong; Tian, Jianfei; Cui, Yanfen; Ren, Sixin; Zuo, Xiaoyan; Tian, Ran; Niu, Ruifang; Zhang, Fei

doi:10.7150/thno.72404

Nanotheranostics 2025; 9(1): 20-30. Full text PDF

Nanotheranostics 2025; 9(1): 1-19. Full text PDF

Nanotheranostics

International Journal of Biological Sciences

International Journal of Medical Sciences

Journal of Cancer

open access Global reach, higher impact

Full Text | PDF

Theranostics 2022; 12(9):4127-4146. doi:10.7150/thno.72404 This issue Cite

Research Paper

Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling

Baoai Han^1,2,3,4, He Zhang^1,2,3,4, Ruinan Tian^1,2,3,4, Hui Liu^1,2,3,4, Zhaosong Wang^1,2,3,4, Zhiyong Wang^1,2,3,4, Jianfei Tian^1,2,3,4, Yanfen Cui^1,2,3,4, Sixin Ren^1,2,3,4, Xiaoyan Zuo^1,2,3,4, Ran Tian^1,2,3,4, Ruifang Niu^1,2,3,4,✉, Fei Zhang^1,2,3,4,✉

1. Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
2. Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.
3. Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
4. Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin, 300060, China.

Citation:

Han B, Zhang H, Tian R, Liu H, Wang Z, Wang Z, Tian J, Cui Y, Ren S, Zuo X, Tian R, Niu R, Zhang F. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Theranostics 2022; 12(9):4127-4146. doi:10.7150/thno.72404. https://www.thno.org/v12p4127.htm

Other styles

Abstract

Rationale: Angiogenesis is a fundamental process of tumorigenesis, growth, invasion and metastatic spread. Extracellular vesicles, especially exosomes, released by primary tumors promote angiogenesis and cancer progression. However, the mechanism underlying the pro-angiogenic potency of cancer cell-derived exosomes remains poorly understood.

Methods: Exosomes were isolated from breast cancer cells with high metastatic potential (HM) and low metastatic potential (LM). The pro-angiogenic effects of these exosomes were evaluated by in vitro tube formation assays, wound healing assays, rat arterial ring budding assays and in vivo Matrigel plug assays. Subsequently, RNA sequencing, shRNA-mediated gene knockdown, overexpression of different EPHA2 mutants, and small-molecule inhibitors were used to analyze the angiogenesis-promoting effect of exosomal EPHA2 and its potential downstream mechanism. Finally, xenograft tumor models were established using tumor cells expressing different levels of EPHA2 to mimic the secretion of exosomes by tumor cells in vivo, and the metastasis of cancer cells were monitored using the IVIS Spectrum imaging system and Computed Tomography.

Results: Herein, we demonstrated that exosomes produced by HM breast cancer cells can promote angiogenesis and metastasis. EPHA2 was rich in HM-derived exosomes and conferred the pro-angiogenic effect. Exosomal EPHA2 can be transferred from HM breast cancer cells to endothelial cells. Moreover, it can stimulate the migration and tube-forming abilities of endothelial cells in vitro and promote angiogenesis and tumor metastasis in vivo. Mechanistically, exosomal EPHA2 activates the AMPK signaling via the ligand Ephrin A1-dependent canonical forward signaling pathway. Moreover, inhibition of the AMPK signaling impairs exosomal EPHA2-mediated pro-angiogenic effects.

Conclusion: Our findings identify a novel mechanism of exosomal EPHA2-mediated intercellular communication from breast cancer cells to endothelial cells in the tumor microenvironment to provoke angiogenesis and metastasis. Targeting the exosomal EPHA2-AMPK signaling may serve as a potential strategy for breast cancer therapy.

Keywords: exosomes, angiogenesis, high metastatic potential cells, breast cancer, EPHA2

Citation styles

APA

Han, B., Zhang, H., Tian, R., Liu, H., Wang, Z., Wang, Z., Tian, J., Cui, Y., Ren, S., Zuo, X., Tian, R., Niu, R., Zhang, F. (2022). Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Theranostics, 12(9), 4127-4146. https://doi.org/10.7150/thno.72404.

ACS

Han, B.; Zhang, H.; Tian, R.; Liu, H.; Wang, Z.; Wang, Z.; Tian, J.; Cui, Y.; Ren, S.; Zuo, X.; Tian, R.; Niu, R.; Zhang, F. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Theranostics 2022, 12 (9), 4127-4146. DOI: 10.7150/thno.72404.

NLM

CSE

Han B, Zhang H, Tian R, Liu H, Wang Z, Wang Z, Tian J, Cui Y, Ren S, Zuo X, Tian R, Niu R, Zhang F. 2022. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling. Theranostics. 12(9):4127-4146.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.